Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 02:45PM GMT
Release Date Price: $31.85 (+1.59%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good morning, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing our 40th health care conference this morning with Ionis. I'm joined by the company's CEO, Brett Monia, who is also one of the founding scientists for Ionis. And he's going to give a presentation on the business, followed by a Q&A session. (Operator Instructions) So with that, over to you, Brett.

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Thank you, Jess. I appreciate it. Good morning, everybody, and thanks for joining us for today's presentation to provide an update on Ionis. I'm very pleased to provide an update at this year's JPMorgan Healthcare Conference. I understand that the slides could be a little bit out of the sync. So I'll try to remember to report slide number or advance -- that I'm advancing to the next slide. These are my forward-looking statements, which I recommend to everybody to review at your convenience.

So moving on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot